 |
Glyceol |
|---|---|
| Trade Name | |
| Orphan Indication | To decrease intracranial hypertension and/or alleviate cerebral edema in patients who may benefit from osmotherapy |
| USA Market Approval | USA |
| USA Designation Date | 1990-02-22 00:00:00 |
| Sponsor | Chugai Pharmaceutical Co., Ltd.;; |
